Prenetics Global shares fell 38% to $10.08 on Wednesday, setting a new 52-week low, after the Hong Kong-based health company reported a wider third-quarter loss and cut its second-half earnings outlook. The stock is down 36% year to date.
Prenetics reported a third-quarter loss of $25.4 million, or $1.45 a share, compared with a loss of $8.7 million, or 53 cents a share, a year earlier. The latest quarter included a $7.2 million noncash fair-value loss on warrant liabilities.
Revenue more than tripled to $64.1 million, topping the $63.2 million analysts polled by FactSet had expected.
The company now expects adjusted earnings before interest, taxes, depreciation and amortization for the second half of the year to show a loss of $30 million to $35 million. Its previous guidance was for a loss of $8 million to $12 million. Prenetics said it revised the outlook because it chose to acquire more customers while returns on them are strong.
Comments (0)
No comments yet. Be the first!